Corvus Pharmaceuticals Stock Price - CRVS

3.66
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
3.66
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Corvus Pharmaceuticals Inc CRVS NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
-0.39 -9.63% 3.66 3.62 4.109 4.06 4.05 19:45:45
Bid Price Ask Price Spread Spread % News
3.55 4.05 0.50 12.35% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
707 115,708 $ 3.82 $ 441,821 142,335 1.01 - 8.10
Last Trade Time Type Quantity Stock Price Currency
16:00:00 1,184 $ 3.66 USD

Corvus Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 102.31M 27.95M 27.69M $ - $ - -1.59 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% 6.00 0.90%

more financials information »

Corvus Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRVS Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.664.203.4753.90179,7200.000.0%
1 Month2.514.242.123.33201,5361.1545.82%
3 Months3.795.441.012.82147,651-0.13-3.43%
6 Months3.036.401.013.86180,9420.6320.79%
1 Year4.018.101.014.04172,798-0.35-8.73%
3 Years11.0017.6351.016.52117,026-7.34-66.73%
5 Years15.0022.13661.017.77106,720-11.34-75.6%

Corvus Pharmaceuticals Description

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small-molecule and antibody agents that target the immune system to treat patients with cancer. The firm's pipeline includes CPI-006, CPI-818, CPI-935, and others.


Your Recent History
NASDAQ
CRVS
Corvus Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.